| Literature DB >> 11181798 |
Andrew O Jones1,2, Jordana Tzenova1, Danielle Frappier2, M Joyce Crumley2, Nicole M Roslin2, Claudine H Kos1, Martin Tieder3, Craig B Langman4, Willem Proesmans5, Thomas O Carpenter6, Allan Rice6, Donald Anderson7, Kenneth Morgan8,9,2, T Mary Fujiwara8,9,2, Harriet S Tenenhouse1,8,10,2.
Abstract
Hereditary hypophosphatemic rickets with hypercalciuria (HHRH), a renal phosphate (Pi) wasting disease first described in an extended Bedouin kindred, is characterized by hypophosphatemia, elevated serum 1,25-dihydroxyvitamin D levels, hypercalciuria, rickets, and osteomalacia. Correction of all abnormalities, except for renal Pi wasting, can be achieved by oral Pi supplementation. These findings and the demonstration that mice that are homozygous for the disrupted Na/Pi cotransporter gene Npt2 exhibit many of the biochemical features of HHRH suggested that mutations in the human orthologue NPT2 might be responsible for HHRH. The NPT2 gene in affected individuals from the Bedouin kindred and four small families was screened for mutations to test this hypothesis. No putative disease-causing mutation was found. Two single nucleotide polymorphisms (SNP), a silent substitution in exon 7 and a nucleotide substitution in intron 4, were identified, and neither consistently segregated with HHRH in the Bedouin kindred. Linkage analysis indicated that the two NPT2 intragenic SNP as well as five microsatellite markers in the NPT2 gene region were not linked to HHRH in the Bedouin kindred. Therefore, this is evidence to exclude NPT2 as a candidate gene for HHRH in the families that were studied.Entities:
Mesh:
Substances:
Year: 2001 PMID: 11181798 DOI: 10.1681/ASN.V123507
Source DB: PubMed Journal: J Am Soc Nephrol ISSN: 1046-6673 Impact factor: 10.121